FR2877576B1 - PHARMACEUTICAL COMPOSITION FOR STIMULATING MASTOCYTE PROLIFERATION AND ACTIVATION - Google Patents

PHARMACEUTICAL COMPOSITION FOR STIMULATING MASTOCYTE PROLIFERATION AND ACTIVATION

Info

Publication number
FR2877576B1
FR2877576B1 FR0411872A FR0411872A FR2877576B1 FR 2877576 B1 FR2877576 B1 FR 2877576B1 FR 0411872 A FR0411872 A FR 0411872A FR 0411872 A FR0411872 A FR 0411872A FR 2877576 B1 FR2877576 B1 FR 2877576B1
Authority
FR
France
Prior art keywords
mastocyte
stimulating
proliferation
activation
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0411872A
Other languages
French (fr)
Other versions
FR2877576A1 (en
Inventor
Ahmed Kadri
Fatima Basri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0411872A priority Critical patent/FR2877576B1/en
Publication of FR2877576A1 publication Critical patent/FR2877576A1/en
Application granted granted Critical
Publication of FR2877576B1 publication Critical patent/FR2877576B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0411872A 2004-11-08 2004-11-08 PHARMACEUTICAL COMPOSITION FOR STIMULATING MASTOCYTE PROLIFERATION AND ACTIVATION Expired - Fee Related FR2877576B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0411872A FR2877576B1 (en) 2004-11-08 2004-11-08 PHARMACEUTICAL COMPOSITION FOR STIMULATING MASTOCYTE PROLIFERATION AND ACTIVATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0411872A FR2877576B1 (en) 2004-11-08 2004-11-08 PHARMACEUTICAL COMPOSITION FOR STIMULATING MASTOCYTE PROLIFERATION AND ACTIVATION

Publications (2)

Publication Number Publication Date
FR2877576A1 FR2877576A1 (en) 2006-05-12
FR2877576B1 true FR2877576B1 (en) 2007-03-09

Family

ID=34951486

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0411872A Expired - Fee Related FR2877576B1 (en) 2004-11-08 2004-11-08 PHARMACEUTICAL COMPOSITION FOR STIMULATING MASTOCYTE PROLIFERATION AND ACTIVATION

Country Status (1)

Country Link
FR (1) FR2877576B1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006035202A1 (en) * 2006-07-29 2008-01-31 Lanxess Deutschland Gmbh Use of a carboxylic acid anhydride as additive in technical materials, cosmetics, pharmaceuticals and food, and for their protection from infestation and/or destruction by micro-organisms such as bacteria, fungi, yeasts and algae
FR2912310B1 (en) * 2007-02-13 2009-08-07 Kasan Sarl NOVEL COSMETIC AND / OR PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATIONS.
EP2862598A1 (en) 2013-10-16 2015-04-22 Legacy Healthcare Holding Ltd. Use of a composition for the pigmentation of hair and hairs
DK3065751T3 (en) 2013-11-08 2020-03-09 Legacy Healthcare Ltd METHOD FOR TREATING CANCER AND CANCER COMORBIDITY
US11872296B2 (en) 2018-06-04 2024-01-16 Conopco, Inc. Preservation compositions
MX2020012640A (en) * 2018-06-04 2021-01-29 Unilever Ip Holdings B V Preservation compositions.
CN112154012B (en) 2018-06-04 2023-10-03 联合利华知识产权控股有限公司 Preservative composition
WO2022122175A1 (en) 2020-12-11 2022-06-16 Herb-Pharma Ag Antiviral composition comprising cistus and medical device for its administration
WO2022238965A1 (en) * 2021-05-12 2022-11-17 Argenta Innovation Limited Veterinary transdermal formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663542B1 (en) * 1990-06-26 1992-09-18 Jouveinal Sa METHOD OF TREATING AN ALOPECIC SURFACE IN MAN AND LOTION FOR ITS IMPLEMENTATION AND FOR TREATING THE SKIN.
US6355684B1 (en) * 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
DE19523320A1 (en) * 1995-06-27 1997-01-02 Henkel Ecolab Gmbh & Co Ohg Disinfectant concentrate contg. terpene cpd(s).
GB9612403D0 (en) * 1996-06-13 1996-08-14 Sandoz Ltd Organic compounds
US5939050A (en) * 1997-04-04 1999-08-17 Optiva Corp. Antimicrobial compositions
US6572849B2 (en) * 2000-09-20 2003-06-03 Lee Shahinian, Jr. Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications
FR2826866B1 (en) * 2001-07-03 2005-12-30 Ahmed Kadri HAIR LOTION PROMOTING HAIR REPELLENT

Also Published As

Publication number Publication date
FR2877576A1 (en) 2006-05-12

Similar Documents

Publication Publication Date Title
IL180517A0 (en) Novel statin pharmaceutical compositions and related methods of treatment
IL182847A0 (en) Pharmaceutical compositions and kits containing vx-950 for treating hepatitis c
SI1679058T1 (en) Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases
IL219150A0 (en) Viral polymerase inhibitors and pharmaceutical compositions comprising thereof
HK1084883A1 (en) 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
GB0614886D0 (en) Pharmaceutical composition and method of the transdermal delivery of magnesium
IL181779A (en) Class of therapeutic protein based molecules
ZA200504239B (en) Pharmaceutical suspension composition
DE60308035D1 (en) VACUUM BINDING SEDICANS COMPOSITION AND ARTICLES INCLUDING THEM
EP1773369A4 (en) Pharmaceutical compositions and methods for peptide treatment
DK1395242T3 (en) Liquid pharmaceutical composition
IL221395A0 (en) Pharmaceutical compositions comprising alpha ketoamide derivatives and uses thereof
EP1765373A4 (en) Ozonidzed pharmaceutical composition and method
DE60335169D1 (en) Glass composition for poling and glass product containing this composition
FR2877576B1 (en) PHARMACEUTICAL COMPOSITION FOR STIMULATING MASTOCYTE PROLIFERATION AND ACTIVATION
ATE539746T1 (en) COMPOSITION FOR IMPROVING COGNITION AND MEMORY
HK1108636A1 (en) Substituted acrylamide derivative and pharmaceutical composition comprising the same
ATE472821T1 (en) COMPOSITIONS FOR DELIVERING MERCURY AND DEVICE THEREFOR
DE60329614D1 (en) POLYMERIC COMPOSITION AND PHARMACEUTICAL FORMS CONTAINING THEREOF
IL184267A0 (en) Detection of schizophrenia and related disorders and pharmaceutical compositions for treating them
FR2888750B1 (en) COMPOSITION FOR PREVENTING AND TREATING CARDIOVASCULAR DISEASES
ZA200702784B (en) Pharmaceutical composition for treatment of tear and salivary fluid drying
ZA200701916B (en) Novel statin pharmaceutical compositions and related methods of treatment
IL179209A0 (en) Small molecules for treatment of hypercholesterolemia and related diseases
IL177751A0 (en) Pharmaceutical composition of (+)-erythro-mefloquine and its use

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20070731